Related Experiment Video
Updated: Aug 5, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Team-based care with early recognition and treatment of cardiac dysfunction for infants with CDH
Patrick E Sloan1, Lila S Sanning2, Caren Liviskie3
1Division of Newborn Medicine, Department of Pediatrics, Washington University in St. Louis, St. Louis, MO, USA. sloan.patrick@wustl.edu.
Insights
A specialized congenital diaphragmatic hernia (CDH) team and early cardiac dysfunction treatment significantly improved infant survival rates and reduced the need for ECMO (extracorporeal membrane oxygenation).
Area of Science:
- Neonatal surgery
- Pediatric cardiology
- Critical care medicine
Background:
- Congenital diaphragmatic hernia (CDH) presents significant challenges in neonatal care.
- Cardiac dysfunction is a major contributor to mortality in infants with CDH.
- Optimizing management strategies is crucial for improving outcomes.
Purpose of the Study:
- To evaluate the impact of a multidisciplinary core congenital diaphragmatic hernia (CDH) team.
- To assess the effect of early recognition and treatment of cardiac dysfunction on infant outcomes.
- To identify changes in management protocols and their correlation with survival and resource utilization.
Main Methods:
- Retrospective chart review comparing two cohorts: historical (2015-2019) and post-guideline implementation (2020-2025).
- Statistical analysis included Fisher's exact test, unpaired t-test, and Mann Whitney U-test.
- Focus on outcomes such as survival, extracorporeal membrane oxygenation (ECMO) utilization, and vasoactive/inotropic agent use.
Main Results:
- Survival improved significantly from 68.6% to 88.7% (p=0.016).
- ECMO utilization decreased from 51.0% to 26.4% (p=0.015).
- Infants with cardiac dysfunction showed improved survival (47.3% vs. 81.8%, p=0.014) and reduced ECMO use (68.4% vs. 36.3%, p=0.043).
- Vasoactive medication strategies shifted, with decreased use of inhaled nitric oxide (iNO) and increased use of prostaglandin E1 (PGE1).
Conclusions:
- Implementation of a core CDH team and a physiology-driven approach to cardiac dysfunction improved survival.
- Standard neonatal echocardiography is effective for identifying and managing cardiac dysfunction in CDH.
- The findings support a standardized, multidisciplinary approach for managing infants with congenital diaphragmatic hernia.
Objective:
Identify how a core congenital diaphragmatic hernia (CDH) team coupled with early recognition and treatment of cardiac dysfunction changed outcomes for infants with CDH.
Methods:
A retrospective chart review compared a historical cohort from 2015-2019 (n = 51) with a post-guideline cohort from 2020-2025 (n = 53). Statistical analysis was performed with Fisher's exact, unpaired t-test, and Mann Whitney U-test.
Results:
Survival improved from 68.6% to 88.7% (p = 0.016) and ECMO utilization decreased, 51.0% to 26.4% (p = 0.015). Infants with cardiac dysfunction had increased survival (47.3% vs. 81.8%, p = 0.014) and less ECMO utilization (68.4% vs. 36.3%, p = 0.043). Vasoactive choices evolved with dopamine replaced by norepinephrine, low-dose epinephrine, or calcium gluconate. Inhaled nitric oxide (iNO) use in the first 48 h decreased significantly while prostaglandin E1 (PGE1) use increased.
Discussion:
We implemented a core CDH team focused on a generalizable, physiology-driven approach to identify and treat cardiac dysfunction using standard neonatal echocardiography to improve outcomes.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview

